These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 18402527)

  • 1. Inflammation in the development of lung cancer: epidemiological evidence.
    Engels EA
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):605-15. PubMed ID: 18402527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer.
    Lee G; Walser TC; Dubinett SM
    Curr Opin Pulm Med; 2009 Jul; 15(4):303-7. PubMed ID: 19417670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of lung cancer following nonmalignant respiratory conditions: evidence from two case-control studies in Montreal, Canada.
    Ramanakumar AV; Parent ME; Menzies D; Siemiatycki J
    Lung Cancer; 2006 Jul; 53(1):5-12. PubMed ID: 16733074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lung cancer in chronic inflammatory processes of the bronchi and pulmonary tissue].
    Smirnov EA
    Vopr Onkol; 1976; 22(6):23-8. PubMed ID: 969340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XRCC1 polymorphism and lung cancer risk.
    Schneider J; Classen V; Helmig S
    Expert Rev Mol Diagn; 2008 Nov; 8(6):761-80. PubMed ID: 18999926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer.
    Landvik NE; Hart K; Skaug V; Stangeland LB; Haugen A; Zienolddiny S
    Carcinogenesis; 2009 Jul; 30(7):1186-92. PubMed ID: 19461122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XRCC1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis.
    Zheng H; Wang Z; Shi X; Wang Z
    Lung Cancer; 2009 Sep; 65(3):268-73. PubMed ID: 19329222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apurinic/apyrimidinic endonuclease (APE1) gene polymorphisms and lung cancer risk in relation to tobacco smoking.
    Agaçhan B; Küçükhüseyin O; Aksoy P; Turna A; Yaylim I; Görmüs U; Ergen A; Zeybek U; Dalan B; Isbir T
    Anticancer Res; 2009 Jun; 29(6):2417-20. PubMed ID: 19528510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
    Corson MA; Jones PH; Davidson MH
    Am J Cardiol; 2008 Jun; 101(12A):41F-50F. PubMed ID: 18549871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population.
    Improta G; Sgambato A; Bianchino G; Zupa A; Grieco V; La Torre G; Traficante A; Cittadini A
    Anticancer Res; 2008; 28(5B):2941-6. PubMed ID: 19031937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Previous pulmonary disease and family cancer history increase the risk of lung cancer among Hong Kong women.
    Wang XR; Yu IT; Chiu YL; Qiu H; Fu Z; Goggins W; Au JS; Tse LA; Wong TW
    Cancer Causes Control; 2009 Jul; 20(5):757-63. PubMed ID: 19169896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP1A2 genetic polymorphisms and adenocarcinoma lung cancer risk in the Tunisian population.
    B'chir F; Pavanello S; Knani J; Boughattas S; Arnaud MJ; Saguem S
    Life Sci; 2009 May; 84(21-22):779-84. PubMed ID: 19332078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A polymorphism in the APE1 gene promoter is associated with lung cancer risk.
    Lo YL; Jou YS; Hsiao CF; Chang GC; Tsai YH; Su WC; Chen KY; Chen YM; Huang MS; Hu CY; Chen CJ; Hsiung CA
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):223-9. PubMed ID: 19124501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis.
    Li H; Hao X; Zhang W; Wei Q; Chen K
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1739-45. PubMed ID: 18628426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric obesity: an inflammatory condition?
    Sacheck J
    JPEN J Parenter Enteral Nutr; 2008; 32(6):633-7. PubMed ID: 18974243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [C-reactive protein and risk of ischaemic vascular and cerebrovascular disease--secondary publication].
    Zacho J; Tybjaerg-Hansen A; Jensen JS; Grande P; Sillesen H; Nordestgaard BG
    Ugeskr Laeger; 2009 May; 171(21):1751-5. PubMed ID: 19492468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?
    Nordestgaard BG; Zacho J
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):521-4. PubMed ID: 19695857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactive effect of cigarette smoking with human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) polymorphisms on the risk of lung cancer: a case-control study in Taiwan.
    Chang CH; Hsiao CF; Chang GC; Tsai YH; Chen YM; Huang MS; Su WC; Hsieh WS; Yang PC; Chen CJ; Hsiung CA
    Am J Epidemiol; 2009 Sep; 170(6):695-702. PubMed ID: 19671832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of DNA repair gene XRCC1 and lung cancer susceptibility among nonsmoking Chinese women.
    Yin J; Vogel U; Ma Y; Qi R; Wang H
    Cancer Genet Cytogenet; 2009 Jan; 188(1):26-31. PubMed ID: 19061777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.